Russia Clinical Trial Market Sales Revenue Opportunity Report Analysis

The Russian clinical trial market accounts for a significant share in the global clinical trial market. The country has got the population and the prevalence of diseases which cater as a good pool of subjects for conducting the studies. The high quality of the regulations followed in the Russian market for clinical trials has led to better optimization of the studies. The Russian clinical trials market enjoys high speed of conducting studies owing to the high patient recruitment rates. The number of clinical trials conducted in Russia by foreign sponsors has tripled in the last decade. The quality of the clinical trials in Russia has been accepted by regulatory agencies such as the FDA and the EMA. The FDA inspection has rated Russia as having a standard quality of investigators leading to low deficiency rate. Russia has caught the attraction of big players in the pharmaceuticals industry, which has led to huge investments by these companies.

Download Report:

https://www.kuickresearch.com/report-Russia-Clinical-Trial-Market-Opportunity-Analysis.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

"Russia Clinical Trial Market Opportunity Analysis" Table of Contents

1. Russia Clinical Trial Market Overview
1.1 Market Overview
1.2 Factors Driving the Market
1.3 Challenges to be resolved

2. Disease Prevalence in Russia
2.1 Non-Communicable Diseases
2.2 Communicable Diseases

3. Clinical Trial Market by Segment
3.1 By Phase
3.2 By Therapeutic Area
3.3 By Domestic & International Sponsors

4. Patient Recruitment & Cost Analysis

5. Regulatory & Policy Framework
5.1 Rules for Import and Export of Biological Materials Obtained in Clinical Trials
5.2 Rules for Accreditation of Medical Institutions for the Right to Conduct Clinical Trials
5.3 Compulsory Insurance of Patient Involved in Clinical Trials
5.4 Procedure of Import of Medicines

6. Key CRO
6.1 Synergy Research Group
6.2 Cromos Pharma
6.3 OCT
6.4 MatrixPharm
6.5 CONGENIX
6.6 Parexel
6.7 Global Clinical Trials
6.8 Quintiles

Figure 1-1: Clinical Trial Market (US$ Million), 2012-2018
Figure 1-2: Clinical Trials Market by Type of Sponsors, 2012
Figure 1-3: Factors Driving the Growth of the Clinical Trial Market
Figure 2-1: Share Communicable & Non-Communicable Diseases, 2012
Figure 3-1: Share of Clinical Trials Market by Phase (%), 2012
Figure 3-2: Number Clinical Trials Market by Phase, 2011 & 2012
Figure 3-3: Clinical Trials by Therapeutic Segment, 2012
Figure 3-4: Clinical Trials Market by Sponsoring Country, 2012
Figure 3-5: Number of Russian & International Sponsors, 2012
Figure 4-1: Trend of Patient Recruitment, 2011-2015
Figure 4-2: Patient Enrolment by Phase (%), 2012

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.